These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 19100524

  • 21. Comparing high and low total body irradiation dose rates for minimum-intensity conditioning of dogs for dog leukocyte antigen-identical bone marrow grafts.
    Graves SS, Storer BE, Butts TM, Storb R.
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1650-4. PubMed ID: 23994246
    [Abstract] [Full Text] [Related]

  • 22. FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease.
    Yunusov MY, Georges GE, Storb R, Moore P, Hagglund H, Affolter V, Lesnikova M, Gass MJ, Little MT, Loken M, McKenna H, Storer B, Nash RA.
    Transplantation; 2003 Apr 15; 75(7):933-40. PubMed ID: 12698076
    [Abstract] [Full Text] [Related]

  • 23. Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells.
    Chang J, Graves SS, Butts-Miwongtum T, Sale GE, Storb R, Mathes DW.
    Transplantation; 2016 Dec 15; 100(12):e120-e127. PubMed ID: 27861292
    [Abstract] [Full Text] [Related]

  • 24. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
    Niemeyer GP, Welch JA, Tillson M, Brawner W, Rynders P, Goodman S, Dufresne M, Dennis J, Lothrop CD.
    Transplant Proc; 2005 Dec 15; 37(10):4579-86. PubMed ID: 16387175
    [Abstract] [Full Text] [Related]

  • 25. Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
    Graves SS, Hogan WJ, Kuhr C, Diaconescu R, Harkey M, Sale GE, Stone B, Georges GE, Storb R.
    Biol Blood Marrow Transplant; 2008 Nov 15; 14(11):1201-8. PubMed ID: 18940673
    [Abstract] [Full Text] [Related]

  • 26. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Nov 15; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 27. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases.
    Niederwieser D, Maris M, Shizuru JA, Petersdorf E, Hegenbart U, Sandmaier BM, Maloney DG, Storer B, Lange T, Chauncey T, Deininger M, Pönisch W, Anasetti C, Woolfrey A, Little MT, Blume KG, McSweeney PA, Storb RF.
    Blood; 2003 Feb 15; 101(4):1620-9. PubMed ID: 12393457
    [Abstract] [Full Text] [Related]

  • 28. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
    Grosskreutz C, Ross V, Scigliano E, Fruchtman S, Isola L.
    Biol Blood Marrow Transplant; 2003 Jul 15; 9(7):453-9. PubMed ID: 12869959
    [Abstract] [Full Text] [Related]

  • 29. Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
    Maris MB, Sandmaier BM, Storer BE, Maloney DG, Shizuru JA, Agura E, Kliem C, Pulsipher M, Maziarz RT, McSweeney PA, Wade J, Langston AA, Chauncey TR, Bruno B, Blume KG, Storb R.
    Biol Blood Marrow Transplant; 2006 Apr 15; 12(4):454-65. PubMed ID: 16545729
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Everolimus in combination with mycophenolate mofetil as pre- and post-transplantation immunosuppression after nonmyeloablative hematopoietic stem cell transplantation in canine littermates.
    Machka C, Lange S, Werner J, Wacke R, Killian D, Knueppel A, Knuebel G, Vogel H, Lindner I, Roolf C, Murua Escobar H, Junghanss C.
    Biol Blood Marrow Transplant; 2014 Sep 15; 20(9):1301-6. PubMed ID: 24923538
    [Abstract] [Full Text] [Related]

  • 32. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
    McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, Chauncey TR, Gooley TA, Hegenbart U, Nash RA, Radich J, Wagner JL, Minor S, Appelbaum FR, Bensinger WI, Bryant E, Flowers ME, Georges GE, Grumet FC, Kiem HP, Torok-Storb B, Yu C, Blume KG, Storb RF.
    Blood; 2001 Jun 01; 97(11):3390-400. PubMed ID: 11369628
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning.
    Graves SS, Hogan W, Kuhr CS, Diaconescu R, Harkey MA, Georges GE, Sale GE, Zellmer E, Baran SW, Jochum C, Stone B, Storb R.
    Blood; 2007 Jul 01; 110(1):418-23. PubMed ID: 17369487
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.
    Chen Y, Fukuda T, Thakar MS, Kornblit BT, Storer BE, Santos EB, Storb R, Sandmaier BM.
    Cytotherapy; 2011 Nov 01; 13(10):1269-80. PubMed ID: 21846291
    [Abstract] [Full Text] [Related]

  • 37. What role for FTY720, a novel immunosuppressive agent, in canine nonmyeloablative hematopoietic stem cell transplantation?
    Xun CQ, Little MT, Zellmer E, Yu C, Zaucha JM, Sale GE, Storer B, Storb R.
    Transplantation; 2002 Jan 27; 73(2):310-3. PubMed ID: 11821753
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.